# Exploiting the Gut Microbiota and Its Metabolites in Pelvic Cancer

> **NCT05605353** · — · RECRUITING · sponsor: **University of Aberdeen** · enrollment: 450 (estimated)

## Conditions studied

- Pelvic Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** Faecal microbiota sampling and blood sampling

## Key facts

- **NCT ID:** NCT05605353
- **Lead sponsor:** University of Aberdeen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2029-05-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05605353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05605353, "Exploiting the Gut Microbiota and Its Metabolites in Pelvic Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05605353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*